Management of an incidentally discovered pulmonary nodule, European Radiology, vol.20, issue.suppl 2, pp.449-466, 2007. ,
DOI : 10.1093/oxfordjournals.aje.a010153
Management strategies for the solitary pulmonary nodule, Current Opinion in Pulmonary Medicine, vol.10, issue.4, pp.272-278, 2004. ,
DOI : 10.1097/01.mcp.0000130322.11513.c8
Management of solitary pulmonary nodules, Dis Mon, vol.37, pp.271-318, 1991. ,
Clinical Prediction Model To Characterize Pulmonary Nodules, Chest, vol.128, issue.4, pp.2490-2496, 2005. ,
DOI : 10.1378/chest.128.4.2490
Management of an incidentally discovered pulmonary nodule, European Radiology, vol.20, issue.suppl 2, pp.449-466, 2007. ,
DOI : 10.1093/oxfordjournals.aje.a010153
Management strategies for the solitary pulmonary nodule, Current Opinion in Pulmonary Medicine, vol.10, issue.4, pp.272-278, 2004. ,
DOI : 10.1097/01.mcp.0000130322.11513.c8
Management of solitary pulmonary nodules. Disease-a-Month, pp.271-318, 1991. ,
Cancer Statistics, 2001, Cancer statistics, pp.15-36, 2001. ,
DOI : 10.3322/canjclin.51.1.15
Cancer Statistics, 2002, Cancer statistics, pp.23-47, 2002. ,
DOI : 10.3322/canjclin.52.1.23
Management of the Solitary Pulmonary Nodule, Chest, vol.116, issue.6, pp.116-523, 1999. ,
DOI : 10.1378/chest.116.suppl_3.523S
Management of SPN in France. Pathways for definitive diagnosis of solitary pulmonary nodule: a multicentre study in 18 French districts, BMC Cancer, vol.138, issue.1, p.93, 2008. ,
DOI : 10.7326/0003-4819-138-9-200305060-00009
Management of solitary pulmonary nodules, Postgraduate Medicine, vol.153, issue.1, pp.145-150, 1997. ,
DOI : 10.1164/ajrccm.153.1.8542152
The Management and Evaluation of the Solitary Pulmonary Nodule, Chest, vol.66, issue.3, pp.236-239, 1974. ,
DOI : 10.1378/chest.66.3.236
Determinants of overall quality of life in preterminal cancer patients, International Journal of Cancer, vol.39, issue.1, pp.232-235, 2008. ,
DOI : 10.1159/000100450
Quality of life in lung cancer: does disclosure of the diagnosis have an impact?, Lung Cancer, vol.43, issue.2, pp.175-182, 2004. ,
DOI : 10.1016/j.lungcan.2003.08.018
Quality of Life in Patients With Lung Cancer, Chest, vol.113, issue.2, pp.467-481, 1970. ,
DOI : 10.1378/chest.113.2.467
How quality of life data contribute to our understanding of cancer patients' experiences? A study of patients with lung cancer, Quality of Life Research, vol.12, issue.2, pp.157-166, 2003. ,
DOI : 10.1023/A:1022232624891
Is a patient's self-reported healthrelated quality of life a prognostic factor for survival in nonsmall-cell lung cancer patients? A multivariate analysis of 108, 2006. ,
The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy, Radiotherapy and Oncology, vol.55, issue.1, pp.19-25, 2000. ,
DOI : 10.1016/S0167-8140(00)00158-4
Quality of life in lung cancer patients: As an important prognostic factor, C. R. Lung Cancer, vol.31, pp.2-3, 2001. ,
Assessment of Quality-of-Life Outcomes, New England Journal of Medicine, vol.334, issue.13, pp.835-840, 1996. ,
DOI : 10.1056/NEJM199603283341306
Assessment of quality of life: advantages and pitfalls, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy Reviews, vol.104, issue.1, pp.32-35, 2005. ,
DOI : 10.1001/jama.286.23.2956
Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL), Quality of Life Research, vol.2, issue.2, pp.153-159, 1993. ,
Quality of life assessment in oncology: I. Definitions and objectives, Review of Francopoh Psycho-Oncologie, vol.1, pp.7-11, 2005. ,
Does the availability of positron emission tomography modify diagnostic strategies for solitary pulmonary nodules? An observational study in France, BMC Cancer, vol.18, issue.1, p.139, 2009. ,
DOI : 10.1007/s00330-008-0970-5
URL : https://hal.archives-ouvertes.fr/hal-00475551
Validating the SF-36 health survey questionnaire: new outcome measure for primary care., BMJ, vol.305, issue.6846, pp.305-160, 1992. ,
DOI : 10.1136/bmj.305.6846.160
The MOS 36-ltem Short-Form Health Survey (SF-36), Medical Care, vol.30, issue.6, pp.473-783, 1992. ,
DOI : 10.1097/00005650-199206000-00002
Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores, pp.77-488, 2002. ,
Quality of life before and after major lung resection for lung cancer: A prospective follow-up analysis. The Annals of Thoracic Surgery, pp.410-416, 2007. ,
What Happens to Patients Undergoing Lung Cancer Surgery?, Chest, vol.122, issue.1, pp.21-30, 2002. ,
DOI : 10.1378/chest.122.1.21
Health-related quality of life associated with chronic conditions in eight countries: Results from the International Quality of Life Assessment (IQOLA) Project, Quality of Life Research, vol.13, issue.2, pp.283-298, 2004. ,
DOI : 10.1023/B:QURE.0000018472.46236.05
TNM Staging of Lung Cancer, Chest, vol.115, issue.1, pp.233-235, 1999. ,
DOI : 10.1378/chest.115.1.233
R??sultats de la TEP [18F]-FDG dans la stadification pr??op??ratoire des tumeurs pulmonaires, Revue des Maladies Respiratoires, vol.22, issue.4, pp.579-585, 2005. ,
DOI : 10.1016/S0761-8425(05)85610-4
Current Standards of Care in Small-Cell and Non-Small-Cell Lung Cancer, Oncology, vol.61, issue.1, pp.61-64, 2001. ,
DOI : 10.1159/000055386
The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30, Quality of Life Research, vol.311, issue.6, pp.555-567, 1996. ,
DOI : 10.1007/BF00439229
Defining clinically meaningful change in health-related quality of life, Journal of Clinical Epidemiology, vol.56, issue.5, pp.395-407, 2003. ,
DOI : 10.1016/S0895-4356(03)00044-1
Management of the solitary pulmonary nodule: Directed resection, Seminars in Thoracic and Cardiovascular Surgery, vol.14, issue.3, pp.286-291, 2002. ,
DOI : 10.1053/stcs.2002.33430
Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule, The European Journal of Health Economics, vol.12, issue.3, pp.203-214, 2005. ,
DOI : 10.7326/0003-4819-138-9-200305060-00009
The Solitary Pulmonary Nodule*, Chest, vol.123, issue.1, pp.89-96, 2003. ,
DOI : 10.1378/chest.123.1_suppl.89S
Diagnostic Efficacy of PET-FDG Imaging in Solitary Pulmonary Nodules, Chest, vol.104, issue.4, pp.997-1002, 1993. ,
DOI : 10.1378/chest.104.4.997
Test Performance of Positron Emission Tomography and Computed Tomography for Mediastinal Staging in Patients with Non???Small-Cell Lung Cancer, Annals of Internal Medicine, vol.139, issue.11, pp.879-892, 2003. ,
DOI : 10.7326/0003-4819-139-11-200311180-00013
PET scan imaging in oncology, European Journal of Cancer, vol.39, issue.11, pp.1525-1534, 2003. ,
DOI : 10.1016/S0959-8049(03)00374-5
Current role of positron emission tomography in thoracic oncology, Thorax, vol.53, issue.8, pp.703-712, 1998. ,
DOI : 10.1136/thx.53.8.703
La tomographie par????mission de??positons au??18fluorod??soxyglucose (18FDG-TEP) dans??la??prise en??charge du??cancer bronchique non ????petites cellules en??2006, Cancer/Radioth??rapie, vol.11, issue.1-2, pp.16-22, 2006. ,
DOI : 10.1016/j.canrad.2006.10.003
TEP: un nouvel outil d'imagerie fonctionnelles (principe, applications validées, perspectives), Médecine thérapeutique, vol.10, issue.3, pp.170-177, 2004. ,
F Fluorodeoxyglucose Positron Emission Tomography in Patients With Non???Small-Cell Lung Cancer: A Prospective Study, Journal of Clinical Oncology, vol.19, issue.1, pp.111-118, 2001. ,
DOI : 10.1200/JCO.2001.19.1.111
Patients with known or suspected lung cancer: evaluation of clinical management changes due to 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) study, Nuclear Medicine Communications, vol.26, issue.9, pp.831-837, 2005. ,
DOI : 10.1097/01.mnm.0000175787.04553.99
The Impact of Positron Emission Tomography on Clinical Decision Making in a University-Based Multidisciplinary Lung Cancer Practice, Chest, vol.128, issue.2, pp.698-703, 2005. ,
DOI : 10.1378/chest.128.2.698
Cancers broncho-pulmonaires et 18 fluorodéoxyglucose Centre Rene Huguenin, Disponibilité sur Internet, 2006. ,
Cost-effectiveness analysis of strategies introducing FDG-PET into the mediastinal staging of non-small-cell lung cancer from the French healthcare system perspective, Clinical Radiology, vol.60, issue.4, pp.479-492, 2005. ,
DOI : 10.1016/j.crad.2004.10.010
F FDG PET-CT cost effective in lung cancer?, Expert Review of Anticancer Therapy, vol.24, issue.4, pp.471-476, 2007. ,
DOI : 10.1200/JCO.2005.02.4695
Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of nonsmall-cell lung carcinoma, J Nucl Med, vol.37, issue.9, pp.1428-1436, 1996. ,
Analytical decision model for the cost-effective management of solitary pulmonary nodules., Journal of Clinical Oncology, vol.16, issue.6, pp.2113-2125, 1998. ,
DOI : 10.1200/JCO.1998.16.6.2113
Cost-Effectiveness of Alternative Management Strategies for Patients with Solitary Pulmonary Nodules, Annals of Internal Medicine, vol.138, issue.9, pp.724-735, 2003. ,
DOI : 10.7326/0003-4819-138-9-200305060-00009
Decision-Tree Sensitivity Analysis for Cost-Effectiveness of Chest 2-Fluoro-2-D-[18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Pulmonary Nodules (Non-small Cell Lung Carcinoma) in Japan, Chest, vol.117, issue.2, pp.346-353, 2000. ,
DOI : 10.1378/chest.117.2.346
Cost Effectiveness of Positron Emission Tomography for the Management of Potentially Operable Non-Small Cell Lung Cancer in Quebec, Canadian Respiratory Journal, vol.12, issue.1, pp.19-25, 2005. ,
DOI : 10.1155/2005/612387
Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975, Annals of Oncology, vol.17, issue.11, pp.1698-1704, 2006. ,
DOI : 10.1093/annonc/mdl183
The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy, Radiotherapy and Oncology, vol.55, issue.1, pp.19-25, 2000. ,
DOI : 10.1016/S0167-8140(00)00158-4
Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?, Cancer, vol.74, issue.2, pp.333-340, 1999. ,
DOI : 10.1002/1097-0142(19940801)74:3<907::AID-CNCR2820740318>3.0.CO;2-#
L'évaluation dans le domaine de la santé, 1991. ,
Evaluer: une question d'éthique. La Santé de l, homme, vol.345, pp.36-38, 2000. ,
Ethique et Evaluation en Santé In: L'évaluation en santé. De la pratique aux résultats. Flammarion ed, pp.32-34, 2007. ,
Variations in physician practice: the role of uncertainty, Health Affairs, vol.3, issue.2, pp.74-89, 1984. ,
DOI : 10.1377/hlthaff.3.2.74
Small Area Variations in Health Care Delivery: A population-based health information system can guide planning and regulatory decision-making, Science, vol.182, issue.4117, pp.1102-1108, 1973. ,
DOI : 10.1126/science.182.4117.1102
La prise de d??cision en m??decine??: quelques m??canismes mentaux et des conseils pratiques, La Revue de M??decine Interne, vol.26, issue.1, pp.14-17, 2005. ,
DOI : 10.1016/j.revmed.2005.04.012
Diagnostic Reasoning, Annals of Internal Medicine, vol.110, issue.11, pp.893-900, 1989. ,
DOI : 10.7326/0003-4819-110-11-893
Dealing with Uncertainty, Risks, and Tradeoffs in Clinical Decisions, Annals of Internal Medicine, vol.108, issue.3, pp.435-449, 1988. ,
DOI : 10.7326/0003-4819-108-3-435
Clinical epidemiology: a basic science for clinical medicine, 1991. ,
Diagnostic basé sur des faits prouvés : accroître le niveau d'exigence, EBM Journal (édition française), vol.10, issue.5, pp.7-8, 1998. ,
Metadiagnosis, The American Journal of Medicine, vol.75, issue.1, pp.129-137, 1983. ,
DOI : 10.1016/0002-9343(83)91176-2
Diagnostic et prise de décision dans les situations dynamiques, Psychologie Française, vol.39, issue.2, pp.177-192, 1994. ,
Medical Practice Guidelines: Current Activities and Future Directions, Annals of Internal Medicine, vol.113, issue.9, pp.709-714, 1990. ,
DOI : 10.7326/0003-4819-113-9-709
De l'évaluation à la qualité en médecine. Aspects historiques. In: L'évaluation en santé. De la pratique aux résultats, pp.3-10, 2007. ,
Place des usagers dans l'évaluation en santé In: L'évaluation en santé. De la pratiques aux résultats, pp.24-26, 2007. ,
options, recommandations: utilisation de la tomographie par émission de positons au 18FDG en cancérologie, Bull Cancer, pp.23-41, 2003. ,
Design of Prospective Clinical Trials for Assessment of PET, Clinical Positron Imaging, vol.1, issue.3, pp.201-211, 1998. ,
DOI : 10.1016/S1095-0397(98)00016-8
Assessment of the technology for functional imaging in cancer, European Journal of Cancer, vol.38, issue.16, pp.2194-2199, 2002. ,
DOI : 10.1016/S0959-8049(02)00385-4
Technology Assessment for Radiologists, Radiology, vol.230, issue.2, pp.309-314, 2004. ,
DOI : 10.1148/radiol.2302031277
Recherche clinique, évaluation et qualité, Thérapie, vol.53, pp.559-563, 1998. ,
Evaluation des pratiques professionnelles, Rev Epidemiol Sante Publique, vol.48, pp.541-550, 2000. ,
Evaluation des actions de santé, Epidémiologie. Principes et méthodes quantitatives. Les éditions INSERM ed, pp.424-437, 1995. ,
Randomized Controlled Trials Are Not Appropriate for Imaging Technology Evaluation, The Journal of Nuclear Medicine, vol.41, issue.7, pp.1125-1126, 2000. ,
The Planning of Observational Studies of Human Populations, Journal of the Royal Statistical Society. Series A (General), vol.128, issue.2, pp.134-155, 1965. ,
DOI : 10.2307/2344179
Experimental and quasi-experimental designs for evaluating guideline implementation strategies, Family Practice, vol.17, issue.90001, pp.11-16, 2000. ,
DOI : 10.1093/fampra/17.suppl_1.S11
Confounding in publications of observational intervention studies, European Journal of Epidemiology, vol.15, issue.27, pp.413-415, 2007. ,
DOI : 10.3310/hta7270
Observational research methods. Research design II: cohort, cross sectional, and case-control studies, Emergency Medicine Journal, vol.20, issue.1, pp.54-60, 2003. ,
DOI : 10.1136/emj.20.1.54
Evaluating Program Effectiveness In: Evaluation of Health Promotion, Health Education and Disease Prevention Programs, pp.145-150, 1994. ,
Cancer epidemiology in France in 2010, comparison with the USA, Bull Cancer, vol.97, issue.1, pp.47-54, 2010. ,
Mortalité par cancer du poumon en France métropolitaine Analyse de tendance et projection de, 1975. ,
Options et Recommandations: cancer bronchopulmonaire non à petites cellules, 2002. ,
Prognostic assessment of 1310 patients with non???small-cell lung cancer who underwent complete resection from 1980 to 1993, The Journal of Thoracic and Cardiovascular Surgery, vol.116, issue.3, pp.407-411, 1998. ,
DOI : 10.1016/S0022-5223(98)70006-6
Delays in diagnosing cancer. Threat to the patient-physician relationship, Can Fam Physician, vol.49, pp.857-863, 2003. ,
Influence of delay on survival in patients with breast cancer: a systematic review, The Lancet, vol.353, issue.9159, pp.1119-1126, 1999. ,
DOI : 10.1016/S0140-6736(99)02143-1
Diagnostic delay causes more psychological distress in female than in male cancer patients, Anticancer Res, vol.16, issue.2, pp.995-999, 1996. ,
Management of solitary pulmonary nodules, Dis Mon, vol.37, issue.5, pp.271-318, 1991. ,
Cancer Statistics, 2003, Cancer statistics, pp.5-26, 2003. ,
DOI : 10.3322/canjclin.53.1.5
Early lung cancer action project, Cancer, vol.19, issue.5, pp.99-105, 1999. ,
DOI : 10.1038/bjc.1965.32
Screening for Lung Cancer with Low-Dose Spiral Computed Tomography, American Journal of Respiratory and Critical Care Medicine, vol.64, issue.4, pp.508-513, 2002. ,
DOI : 10.1359/jbmr.1997.12.11.1954
Evaluation and Management of the Solitary Pulmonary Nodule, American Journal of Respiratory and Critical Care Medicine, vol.134, issue.3, pp.782-787, 2000. ,
DOI : 10.1378/chest.112.6.1480
Temporal Trends in the Prevalence of Malignancy in Resected Solitary Pulmonary Lesions, Chest, vol.109, issue.1, pp.100-103, 1996. ,
DOI : 10.1378/chest.109.1.100
Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. Theory., Radiology, vol.186, issue.2, pp.405-413, 1993. ,
DOI : 10.1148/radiology.186.2.8421743
Letter from the guest editor, Seminars in Ultrasound, CT and MRI, vol.21, issue.2, pp.95-96, 2000. ,
DOI : 10.1016/S0887-2171(00)90016-7
Solitary Pulmonary Nodules: Part I. Morphologic Evaluation for Differentiation of Benign and Malignant Lesions, RadioGraphics, vol.20, issue.1, pp.43-58, 2000. ,
DOI : 10.1148/radiographics.20.1.g00ja0343
The Solitary Pulmonary Nodule, Archives of Surgery, vol.110, issue.5, pp.570-575, 1975. ,
DOI : 10.1001/archsurg.1975.01360110116019
Evaluation and management of solitary and multiple pulmonary nodules, Clin Chest Med, vol.14, issue.1, pp.111-119, 1993. ,
Solitary pulmonary nodules: CT assessment., Radiology, vol.160, issue.2, pp.307-312, 1986. ,
DOI : 10.1148/radiology.160.2.3726105
Evaluation and management of solitary and multiple pulmonary nodules, Clin Chest Med, vol.13, issue.1, pp.83-95, 1992. ,
CT of the pulmonary nodule: a cooperative study., Radiology, vol.160, issue.2, pp.319-327, 1986. ,
DOI : 10.1148/radiology.160.2.3726107
THE RATE OF GROWTH AND NATURAL DURATION OF PRIMARY BRONCHIAL CANCER, American Journal of Roentgenology, vol.96, issue.3, pp.604-611, 1966. ,
DOI : 10.2214/ajr.96.3.604
The solitary pulmonary nodule, European Journal of Radiology, vol.45, issue.1, pp.69-77, 2003. ,
DOI : 10.1016/S0720-048X(02)00297-8
Small Pulmonary Nodules: Volumetrically Determined Growth Rates Based on CT Evaluation, Radiology, vol.217, issue.1, pp.251-256, 2000. ,
DOI : 10.1148/radiology.217.1.r00oc33251
Differentiation of malignant from benign solitary pulmonary lesions using chest radiography, spiral CT and HRCT, Lung Cancer, vol.29, issue.2, pp.105-124, 2000. ,
DOI : 10.1016/S0169-5002(00)00104-5
The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules, Archives of Internal Medicine, vol.157, issue.8, pp.849-855, 1997. ,
DOI : 10.1001/archinte.157.8.849
Lung Nodule Enhancement at CT: Multicenter Study, Radiology, vol.214, issue.1, pp.73-80, 2000. ,
DOI : 10.1148/radiology.214.1.r00ja1473
Approach to the Solitary Pulmonary Nodule, Mayo Clinic Proceedings, vol.68, issue.4, pp.378-385, 1993. ,
DOI : 10.1016/S0025-6196(12)60136-0
Solitary pulmonary nodules found in a community-wide chest roentgenographic survey; a fiveyear follow-up study, Am Rev Tuberc, vol.79, issue.4, pp.427-439, 1959. ,
The Solitary Pulmonary Nodule*, Chest, vol.123, issue.1, pp.89-96, 2003. ,
DOI : 10.1378/chest.123.1_suppl.89S
Transbronchial Biopsy Guided by Low-Dose MDCT: A New Approach for Assessment of Solitary Pulmonary Nodules, American Journal of Roentgenology, vol.187, issue.4, pp.933-939, 2006. ,
DOI : 10.2214/AJR.05.0763
Repeat needle biopsies combined with clinical observation are safe and accurate in the management of a solitary pulmonary nodule, Cancer, vol.37, issue.3, pp.599-607, 2005. ,
DOI : 10.1053/stcs.2002.33696
Accuracy and complications in computed tomography fluoroscopy-guided needle biopsies of lung masses, European Radiology, vol.121, issue.6, pp.1387-1392, 2006. ,
DOI : 10.1097/01.RVI.0000124951.24134.50
Variables affecting the risk of pneumothorax and intrapulmonal hemorrhage in CT-guided transthoracic biopsy, European Radiology, vol.214, issue.1, pp.1356-1363, 2008. ,
DOI : 10.1148/radiology.214.1.r00ja1473
Risk Factors of Pneumothorax and Bleeding, Chest, vol.126, issue.3, pp.748-754, 2004. ,
DOI : 10.1378/chest.126.3.748
Investigation et prise en charge du nodule pulmonaire solitaire dans un environnement multidisciplinaire, M??decine Nucl??aire, vol.31, issue.8, pp.380-387, 2007. ,
DOI : 10.1016/j.mednuc.2007.06.003
Accuracy of PET/CT in characterization of solitary pulmonary lesions, J Nucl Med, vol.48, issue.2, pp.214-220, 2007. ,
Is There a Role for PET in the Evaluation of Subcentimeter Pulmonary Nodules?, Seminars in Thoracic and Cardiovascular Surgery, vol.17, issue.2, pp.110-114, 2005. ,
DOI : 10.1053/j.semtcvs.2005.04.004
The Utility of Fluorodeoxyglucose Positron Emission Tomography in the Evaluation of Carcinoid Tumors Presenting as Pulmonary Nodules, Chest, vol.131, issue.1, pp.255-260, 2007. ,
DOI : 10.1378/chest.06-0711
Le Cancer du poumon non à petites cellules: d'hier à aujourd'hui, Pharmactuel, vol.35, issue.4, pp.161-169, 2002. ,
Lung cancer, The Lancet, vol.355, issue.9202, pp.479-485, 2000. ,
DOI : 10.1016/S0140-6736(00)82038-3
Current Standards of Care in Small-Cell and Non-Small-Cell Lung Cancer, Oncology, vol.61, issue.1, pp.3-13, 2001. ,
DOI : 10.1159/000055386
SEOM guidelines for the management of non-small-cell lung cancer (NSCLC), Clinical and Translational Oncology, vol.26, issue.[Suppl2], pp.284-289, 2009. ,
DOI : 10.1007/s12094-009-0356-4
STAGING AND THE SURGICAL MANAGEMENT OF LUNG CANCER, Radiologic Clinics of North America, vol.38, issue.3, pp.545-61, 2000. ,
DOI : 10.1016/S0033-8389(05)70184-6
Clinical practice guidelines for for the treatment of unresectable non-small-cell lung cancer, J Clin Oncol, vol.15, issue.8, pp.2996-3018, 1997. ,
Adjuvant and neoadjuvant therapy for early stage non-small cell lung cancer, Seminars in Oncology, vol.28, issue.4 14, pp.23-28, 2001. ,
DOI : 10.1016/S0093-7754(01)90056-9
Update in non-small cell lung cancer, Med Health R I, vol.85, issue.1, pp.7-9, 2002. ,
Induction chemotherapy before surgery for early-stage lung cancer: A novel approach, The Journal of Thoracic and Cardiovascular Surgery, vol.119, issue.3, pp.429-437, 2000. ,
DOI : 10.1016/S0022-5223(00)70120-6
Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial, Lung Cancer, vol.26, issue.1, pp.7-14, 1999. ,
DOI : 10.1016/S0169-5002(99)00045-8
Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer, Lung Cancer, vol.21, issue.1, pp.1-6, 1998. ,
DOI : 10.1016/S0169-5002(98)00046-4
Comprendre la TEP (Tomographie par Emission de Positons au 18FDG) en Cancérologie, 2004. ,
Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass Lesions, JAMA, vol.285, issue.7, pp.914-924, 2001. ,
DOI : 10.1001/jama.285.7.914
Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography, The Annals of Thoracic Surgery, vol.60, issue.5, pp.1348-1352, 1995. ,
DOI : 10.1016/0003-4975(95)00754-9
Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5, J Nucl Med, vol.47, issue.3, pp.426-431, 2006. ,
Les limites du SUV, M??decine Nucl??aire, vol.31, issue.4, pp.165-172, 2007. ,
DOI : 10.1016/j.mednuc.2007.03.003
Positron-emission tomography as a prognostic tool for early-stage lung cancer, The American Journal of Surgery, vol.191, issue.3, pp.433-436, 2006. ,
DOI : 10.1016/j.amjsurg.2005.10.052
The performance of( 18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules, Eur J Nucl Med Mol Imaging, vol.31, issue.9, pp.1231-1236, 2004. ,
Preoperative Staging of Lung Cancer with Combined PET???CT, New England Journal of Medicine, vol.361, issue.1, pp.32-39, 2009. ,
DOI : 10.1056/NEJMoa0900043
Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial, The Lancet, vol.359, issue.9315, pp.1388-1393, 2002. ,
DOI : 10.1016/S0140-6736(02)08352-6
Positron Emission Tomography in Staging Early Lung Cancer, Annals of Internal Medicine, vol.151, issue.4, pp.221-248, 2009. ,
DOI : 10.7326/0003-4819-151-4-200908180-00132
Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling., Radiology, vol.202, issue.2, pp.441-446, 1997. ,
DOI : 10.1148/radiology.202.2.9015071
Tomographie par émission de positons (TEP) et [F-18]-fluorodésoxyglucose (FDG) en cancérologie, Bull Cancer, vol.85, issue.11, pp.935-950, 1998. ,
TEP-TDM pour l???exploration du nodule pulmonaire solitaire??: acquis et perspectives, Revue des Maladies Respiratoires, vol.26, issue.10, pp.1041-1055, 2009. ,
DOI : 10.1016/S0761-8425(09)73531-4
The Maximum Standardized Uptake Values on Integrated FDG-PET/CT Is Useful in Differentiating Benign From Malignant Pulmonary Nodules, The Annals of Thoracic Surgery, vol.82, issue.3, pp.1016-1020, 2006. ,
DOI : 10.1016/j.athoracsur.2006.03.095
Clinical 18F-FDG oncology patient preparation techniques, J Nucl Med Technol, vol.31, issue.1, pp.3-7, 2003. ,
Positron emission tomography scanning for the diagnosis and management of lung cancer, Current Treatment Options in Oncology, vol.54, issue.1, pp.63-73, 2004. ,
DOI : 10.1148/radiology.202.2.9015071
Additional Value of Whole-Body Fluorodeoxyglucose Positron Emission Tomography in the Detection of Distant Metastases of Non???Small-Cell Lung Cancer, Clinical Lung Cancer, vol.4, issue.4, pp.242-247, 2003. ,
DOI : 10.3816/CLC.2003.n.005
PET in lung cancer, J Nucl Med, vol.40, issue.5, pp.814-820, 1999. ,
The Solitary Pulmonary Nodule, Chest, vol.91, issue.1, pp.128-133, 1987. ,
DOI : 10.1378/chest.91.1.128
An Integrated Approach to Evaluation of the Solitary Pulmonary Nodule, Mayo Clinic Proceedings, vol.65, issue.2, pp.173-186, 1990. ,
DOI : 10.1016/S0025-6196(12)65012-5
Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review, The Lancet Oncology, vol.2, issue.11, pp.659-666, 2001. ,
DOI : 10.1016/S1470-2045(01)00555-1
Recommendations on the Use of 18F-FDG PET in Oncology, Journal of Nuclear Medicine, vol.49, issue.3, pp.480-508, 2008. ,
DOI : 10.2967/jnumed.107.047787
The revised TNM staging system for lung cancer, Ann Thorac Cardiovasc Surg, vol.15, issue.1, pp.4-9, 2009. ,
L'imagerie nucléaire au 18FDGdans les lésions pleurales en apparences isolées, Rev Pneumol Clin, vol.59, pp.375-388, 2003. ,
Metabolic Imaging of Malignant Pleural Mesothelioma With Fluorodeoxyglucose Positron Emission Tomography, Chest, vol.114, issue.3, pp.713-722, 1998. ,
DOI : 10.1378/chest.114.3.713
Evaluation of pleural diseases with FDG-PET imaging: preliminary report, Thorax, vol.52, issue.2, pp.187-189, 1997. ,
DOI : 10.1136/thx.52.2.187
Cancer imaging: is it cost-effective?, Cancer Imaging, vol.4, issue.2, pp.97-103, 2004. ,
DOI : 10.1102/1470-7330.2004.0017
Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?, The Annals of Thoracic Surgery, vol.73, issue.2, pp.394-401, 2002. ,
DOI : 10.1016/S0003-4975(01)03432-4
Mediastinal Lymph Node Staging With FDG-PET Scan in Patients With Potentially Operable Non-small Cell Lung Cancer, Chest, vol.112, issue.6, pp.1480-1486, 1997. ,
DOI : 10.1378/chest.112.6.1480
The impact of delayed diagnosis of lung cancer on the stage at the time of operation, European Journal of Cardio-Thoracic Surgery, vol.107, issue.20, pp.880-884, 1997. ,
DOI : 10.1378/chest.107.6_Supplement.270S
Impact of Delay on Diagnosis and Treatment of Primary Lung Cancer, Acta Oncologica, vol.51, issue.5, pp.147-152, 2002. ,
DOI : 10.1136/thx.51.12.1262
Delay in diagnosis of cancer. Possible effects on the stage of disease and survival, Cancer, vol.40, issue.7, pp.1454-1460, 1984. ,
DOI : 10.1016/S0025-7125(16)35623-1
Reporting on quality of life in randomised controlled trials: bibliographic study, BMJ, vol.317, issue.7167, pp.1191-1194, 1998. ,
DOI : 10.1136/bmj.317.7167.1191
Measuring quality of life: an emerging science, Semin Oncol, vol.21, issue.5, pp.48-60, 1994. ,
Tests of Data Quality, Scaling Assumptions, and Reliability of the SF-36 in Eleven Countries, Journal of Clinical Epidemiology, vol.51, issue.11, pp.1149-1158, 1998. ,
DOI : 10.1016/S0895-4356(98)00106-1
The MOS 36-Item Short-Form Health Survey (SF-36), Medical Care, vol.31, issue.3, pp.247-263, 1993. ,
DOI : 10.1097/00005650-199303000-00006
The MOS 36-Item Short-Form Health Survey (SF-36), Medical Care, vol.31, issue.3, pp.40-66, 1994. ,
DOI : 10.1097/00005650-199303000-00006
Measuring patients' views: the optimum outcome measure., BMJ, vol.306, issue.6890, pp.1429-1430, 1993. ,
DOI : 10.1136/bmj.306.6890.1429
The MOS 36-ltem Short-Form Health Survey (SF-36), Medical Care, vol.30, issue.6, pp.473-483, 1992. ,
DOI : 10.1097/00005650-199206000-00002
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology, JNCI Journal of the National Cancer Institute, vol.85, issue.5, pp.365-376, 1993. ,
DOI : 10.1093/jnci/85.5.365
Evaluation of the EORTC QLQ-C30 questionnaire: A comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients, Annals of Oncology, vol.9, issue.5, pp.549-557, 1998. ,
DOI : 10.1023/A:1008264412398
Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores ,
The clinical significance of quality of life assessments in oncology: a summary for clinicians, Supportive Care in Cancer, vol.37, issue.10, pp.988-998, 2006. ,
DOI : 10.1136/bmj.311.7010.899
The Clinical Significance of Quality-of-Life Results: Practical Considerations for Specific Audiences, Mayo Clinic Proceedings, vol.77, issue.6, pp.572-583, 2002. ,
DOI : 10.4065/77.6.572
Standard of Care for Cancer-Related Anemia: Improving Hemoglobin Levels and Quality of Life, Oncology, vol.16, issue.1, pp.22-32, 2005. ,
DOI : 10.1634/theoncologist.7-2-126
The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer, Lung Cancer, vol.12, issue.1-2, pp.45-58, 1995. ,
DOI : 10.1016/0169-5002(94)00392-Z
Quality of life as a predictor of cancer survival among Chinese liver and lung cancer patients, European Journal of Cancer, vol.43, issue.11, pp.1723-1730, 2007. ,
DOI : 10.1016/j.ejca.2007.05.002
Quality of life assessment. An independent prognostic variable for survival in lung cancer, Cancer, vol.318, issue.12, pp.3131-3135, 1991. ,
DOI : 10.1002/1097-0142(19910615)67:12<3131::AID-CNCR2820671232>3.0.CO;2-4
The role of functional status in predicting inpatient mortality with AIDS: A comparison with current predictors, Journal of Clinical Epidemiology, vol.49, issue.2, pp.193-201, 1996. ,
DOI : 10.1016/0895-4356(95)00546-3
Prognostic value of quality of life scores in terminal cancer patients, Journal of Pain and Symptom Management, vol.11, issue.1, pp.32-41, 1996. ,
DOI : 10.1016/0885-3924(95)00135-2
Interpreting the significance of changes in health-related quality-of-life scores., Journal of Clinical Oncology, vol.16, issue.1, pp.139-144, 1998. ,
DOI : 10.1200/JCO.1998.16.1.139
The prognostic value of quality of life scores during treatment for oesophageal cancer, Gut, vol.49, issue.2, pp.227-230, 2001. ,
DOI : 10.1136/gut.49.2.227
Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients, European Journal of Cancer, vol.39, issue.11, pp.1577-1585, 2003. ,
DOI : 10.1016/S0959-8049(03)00372-1
Prognostic implications of BCL6 rearrangement in uniformly treated patients with diffuse large B-cell lymphoma - a Nordic Lymphoma Group study, International Journal of Oncology, vol.20, issue.1, pp.161-165, 2002. ,
DOI : 10.3892/ijo.20.1.161
Prognostic factors and survival in a heterogeneous sample of cancer patients, British Journal of Cancer, vol.73, issue.12, pp.1594-1599, 1996. ,
DOI : 10.1038/bjc.1996.300
Quality of life issues in lung cancer. New symptom management strategies, Chest, vol.103, issue.1, pp.51-55, 1993. ,
DOI : 10.1378/chest.103.1.51S
Quality of life evolution after lung cancer surgery: A prospective study in 100 patients, Lung Cancer, vol.56, issue.3, pp.423-431, 2007. ,
DOI : 10.1016/j.lungcan.2007.01.013
Quality of life in lung cancer patients: impact of baseline clinical profile and respiratory status, European Journal of Cancer Care, vol.23, issue.3, pp.268-276, 2007. ,
DOI : 10.1016/S0167-8140(00)00252-8
Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial, European Journal of Cancer, vol.34, issue.7, pp.1036-1044, 1998. ,
DOI : 10.1016/S0959-8049(97)10122-8
Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?, Cancer, vol.317, issue.7, pp.1271-1278, 1989. ,
DOI : 10.7326/0003-4819-95-4-414
Survie attendue des patients atteints de cancers en France : Etat des lieux, 2010. ,
Revue comparative des mod??les r??gressifs de survie brute et de survie relative, Revue d'??pid??miologie et de Sant?? Publique, vol.53, issue.4, pp.409-417, 2005. ,
DOI : 10.1016/S0398-7620(05)84623-1
In: Survie des patients atteints de cancer en France, Etudes des registres du réseau FRANCIM, pp.185-192, 2007. ,
Prognostic assessment after surgical resection for non-small cell lung cancer: Experiences in 2083 patients, Lung Cancer, vol.55, issue.3, pp.371-377, 2007. ,
DOI : 10.1016/j.lungcan.2006.10.017
New TNM classification for non-small-cell lung cancer, Expert Review of Anticancer Therapy, vol.356, issue.4, pp.413-423, 2009. ,
DOI : 10.1056/NEJMoa060467
Critères d'évaluation des cancers broncho-pulmonaires. Quels critères économiques ?, Rev Mal Respir, vol.23, pp.16-118, 2006. ,
Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule, The European Journal of Health Economics, vol.12, issue.3, pp.203-214, 2005. ,
DOI : 10.7326/0003-4819-138-9-200305060-00009
The Cost-utility Analysis of 18-Fluoro-2-Deoxyglucose Positron Emission Tomography in the Diagnosis of Recurrent Nasopharyngeal Carcinoma, Acad Radiol, vol.16, pp.54-60, 2009. ,
Staging non???small cell lung cancer by whole-body positron emission tomographic imaging, The Annals of Thoracic Surgery, vol.60, issue.6, pp.1573-1581, 1995. ,
DOI : 10.1016/0003-4975(95)00752-0
L'évaluation médico-économique: objectifs, méthodologie, limites, Gastroenterol Clin Biol, vol.24, pp.1029-1031, 2000. ,
Management of SPN in France. Pathways for definitive diagnosis of solitary pulmonary nodule: a multicentre study in 18 French districts, BMC Cancer, vol.138, issue.1, p.93, 2008. ,
DOI : 10.7326/0003-4819-138-9-200305060-00009
Projections of Global Mortality and Burden of Disease from 2002 to 2030, PLoS Medicine, vol.52, issue.11, p.442, 2002. ,
DOI : 10.1371/journal.pmed.0030442.st007
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World, Journal of Clinical Oncology, vol.24, issue.14, pp.2137-2150, 2006. ,
DOI : 10.1200/JCO.2005.05.2308
Cancer incidence and mortality in France over the period 1980???2005, Revue d'??pid??miologie et de Sant?? Publique, vol.56, issue.3, pp.159-175, 1980. ,
DOI : 10.1016/j.respe.2008.03.117
URL : https://hal.archives-ouvertes.fr/hal-00538673
Quality of life in lung cancer patients, Annals of Oncology, vol.12, issue.suppl 3, pp.21-25, 2001. ,
DOI : 10.1093/annonc/12.suppl_3.S21
Fluorodeoxyglucose Uptake of Primary Non-Small Cell Lung Cancer at Positron Emission Tomography: New Contrary Data on Prognostic Role, Clinical Cancer Research, vol.13, issue.11, pp.3255-3263, 2007. ,
DOI : 10.1158/1078-0432.CCR-06-1128
Surveillances des cancers en France: Etats des lieux et perspectives en, Bulletin épidémiologie hebdomadaire, vol.9, issue.10, pp.65-84, 2007. ,
Recent Advances and Future Perspectives in the Management of Lung Cancer, Current Problems in Surgery, vol.42, issue.8, pp.540-610, 2005. ,
DOI : 10.1067/j.cpsurg.2005.05.002
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship, Mayo Clinic Proceedings, vol.83, issue.5, pp.584-594, 2008. ,
DOI : 10.1016/S0025-6196(11)60735-0
Longs survivants de cancers bronchiques non ?? petites cellules stades IIIB-IV. Caract??ristiques et facteurs pronostiques ?? partir d???une s??rie r??trospective, Revue des Maladies Respiratoires, vol.26, issue.9, pp.952-960, 2009. ,
DOI : 10.1016/S0761-8425(09)73330-3
Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial, Lung Cancer, vol.43, issue.2, pp.183-194, 2004. ,
DOI : 10.1016/j.lungcan.2003.09.001
Quality of Life after Lung Cancer Surgery: Video-Assisted Thoracic Surgery versus Thoracotomy, Heart, Lung and Circulation, vol.16, issue.4, pp.285-289, 2007. ,
DOI : 10.1016/j.hlc.2007.02.081
Effect of chemotherapy for advanced non-small cell lung cancer on patients??? quality of life, Lung Cancer, vol.53, issue.2, pp.231-239, 2006. ,
DOI : 10.1016/j.lungcan.2006.05.003
Multi-dimensional quality of life among long-term (5+ years) adult cancer survivors, Psycho-Oncology, vol.13, issue.8, pp.691-706, 2007. ,
DOI : 10.1093/jnci/94.1.39
Quality of Life in Patients With Advanced Non-Small Cell Lung Cancer, Cancer Nursing, vol.29, issue.2, pp.104-110, 2006. ,
DOI : 10.1097/00002820-200603000-00004
Quality of life in newly diagnosed patients with lung cancer in a developing country: is it important?, European Journal of Cancer Care, vol.19, issue.3, pp.293-298, 2006. ,
DOI : 10.1006/pmed.1999.0523
The Problem of Quality of Life in Medicine, JAMA: The Journal of the American Medical Association, vol.278, issue.1, pp.47-50, 1997. ,
DOI : 10.1001/jama.1997.03550010061041
Lessons learned from measuring health-related quality of life in oncology., Journal of Clinical Oncology, vol.12, issue.3, pp.608-616, 1994. ,
DOI : 10.1200/JCO.1994.12.3.608
Collecting quality of life data in EORTC clinical trials???what happens in practice?, Psycho-Oncology, vol.5, issue.3, pp.260-263, 1999. ,
DOI : 10.1007/BF00435963
Validating the SF-36 health survey questionnaire: new outcome measure for primary care., BMJ, vol.305, issue.6846, pp.160-164, 1992. ,
DOI : 10.1136/bmj.305.6846.160
Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection, Statistics in Medicine, vol.6, issue.24, pp.3865-3884, 2002. ,
DOI : 10.1023/A:1018491512095
Regression Models and Life-Tables, J Royal Stat Soc, vol.4, pp.187-220, 1972. ,
DOI : 10.1007/978-1-4612-4380-9_37
Assessment of Model Adequacy Applied Survival Analysis. Regression Modeling of Tine-to-Event Data, pp.169-206, 2008. ,
SURVIVAL ANALYSIS IN PUBLIC HEALTH RESEARCH, Annual Review of Public Health, vol.18, issue.1, pp.105-134, 1997. ,
DOI : 10.1146/annurev.publhealth.18.1.105
Assessment of Quality of Life in the Supportive Care Setting of the Big Lung Trial in Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.23, issue.30, pp.7417-7427, 2005. ,
DOI : 10.1200/JCO.2005.09.158
Quality of life in lung cancer patients: as an important prognostic factor, Lung Cancer, vol.31, pp.2-3, 2001. ,
Chemotherapy improves low performance status lung cancer patients, European Respiratory Journal, vol.30, issue.6, pp.1186-1192, 2007. ,
DOI : 10.1183/09031936.00034507
Psychological Coping Mechanisms and Survival Time in Metastatic Breast Cancer, JAMA: The Journal of the American Medical Association, vol.242, issue.14, pp.1504-1508, 1979. ,
DOI : 10.1001/jama.1979.03300140020016
Anxiety, depression and quality of life of cancer patients undergoing radiation therapy: a cross-sectional study in a community hospital outpatient centre, European Journal of Cancer Care, vol.67, issue.2, pp.130-136, 2007. ,
DOI : 10.1002/1097-0142(20000815)89:4<873::AID-CNCR21>3.0.CO;2-K
Predicting survival in advanced cancer patients: is it possible with patient-reported health status data?, Annals of Oncology, vol.17, issue.7, pp.1037-1038, 2006. ,
DOI : 10.1093/annonc/mdl065
Valeur pronostique des mesures de qualité de vie en cancérologie, Rev Francoph Psycho-Oncologie, vol.1, pp.23-28, 2005. ,
L'évaluation des technologies médicales, ADSP, vol.39, pp.28-33, 2002. ,
Dialogue entre le radiologue et le patient atteint d???un cancer, Journal de Radiologie, vol.87, issue.2, pp.99-104, 2006. ,
DOI : 10.1016/S0221-0363(06)73978-6
Management of SPN in France. Pathways for definitive diagnosis of solitary pulmonary nodule: a multicentre study in 18 French districts, BMC Cancer, vol.138, issue.1, p.93, 2008. ,
DOI : 10.7326/0003-4819-138-9-200305060-00009
Clinical Costeffectiveness analysis of strategies introducing FDG-PET into the mediastinal staging of nonsmall-cell lung cancer from the French healthcare system perspective, Radiology, pp.60-479, 2005. ,
Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule, Eur J Health Econom, vol.50, pp.203-214, 2005. ,
Use of a Decision Analysis Model to Assess the Cost-Effectiveness of 18F-FDG PET in the Management of Metachronous Liver Metastases of Colorectal Cancer ,
Does the Availability of Positron Emission Tomography modify Diagnostic Strategies for Solitary Pulmonary Nodules? An Observational Study in France, Publié: BMC Cancer, vol.9, p.139, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00475551
Solitary Pulmonary Nodule: consequences for patient quality of life, Publié: Quality of Life Research, vol.20, issue.1, pp.101-109, 2011. ,
Modélisation médicoéconomique de la caméra TEP en cas de lymphomeEvaluation en santé publique, 2002. ,
Analyse coût-efficacité de la tomographie par émission de positons pour le bilan d'extension médiastinale de cancer du poumon non à petites cellules. Revue d'Epidémiologie et de Santé Publique, pp.1-30, 2004. ,
La prise en charge du nodule pulmonaire isolé en France : une cohorte prospective, 2005. ,
Les trajectoires de soins des patients ayant un nodule pulmonaire isolé : étude multicentrique dans 18 départements de l'inter-région Nord-Est, 2006. ,
La tomographie par émission de positon (TEP) modifie t-elle la prise en charge diagnostique du nodule pulmonaire isolé (NPI) ? 2 ième Conférence francophone d'épidémiologie clinique ADELF, pp.23-23, 2008. ,
La tomographie par émission de positon (TEP) modifie t-elle la prise en charge diagnostique du nodule pulmonaire isolé (NPI) ? 2 e Forum du Cancéropôle Grand Est, 2008. ,
Nodule Pulmonaire Isolé (NPI) : Impact sur la qualité de vie (QV) des patients. 3 ième Conférence francophone d'épidémiologie clinique ADELF, 2009. ,
Solitary pulmonary nodules: consequences for patient quality of life, ISOQOL 16th Annual Meeting, pp.28-31, 2009. ,
DOI : 10.1378/chest.123.1_suppl.89S